Approval · Notice of Compliance 8795 · 2007
SUBOXONE: Notice of Compliance 8795
Issued May 18, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8795
- Date
- May 18, 2007
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Partial opiate agonist & opiate antagonist
Products in this notice
Medicinal ingredients
- BUPRENORPHINE HYDROCHLORIDE 2 MG per TAB
- NALOXONE HYDROCHLORIDE DIHYDRATE 0.5 MG per TAB
- BUPRENORPHINE HYDROCHLORIDE 8 MG per TAB
- NALOXONE HYDROCHLORIDE DIHYDRATE 2 MG per TAB